95 results
Page 3 of 5
8-K
EX-99.1
87ja2nkkjx5s 4vopi
7 May 20
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
4:27pm
8-K
EX-99.1
81kx6
7 Apr 20
Sage Therapeutics Announces Restructuring to Advance Corporate Strategy and Pipeline
4:25pm
8-K
7z607k 2l
7 Apr 20
Sage Therapeutics Announces Restructuring to Advance Corporate Strategy and Pipeline
4:25pm
8-K
EX-99.1
c7bxrecoopgea9j
18 Mar 20
Sage Therapeutics Announces Development Plan for Zuranolone(SAGE-217) Following
6:57am
8-K
EX-99.1
c2rmy5c
27 Feb 20
Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
EX-99.1
lo3bxgjzfp2p7gkm7
12 Nov 19
Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights
6:44am
8-K
EX-99.1
2zv8aa 65ef
6 Aug 19
Results of Operations and Financial Condition
7:04am
8-K
EX-99.1
gw1kzyrnmg qw
24 Jul 19
Sage Therapeutics Announces Clinical Updates and Progress Across Neuroscience Pipeline
7:18am
8-K
EX-99.1
4krqdp69aedzzts
14 Jun 19
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSOâ„¢ (brexanolone) Injection
9:03am
8-K
EX-99.1
gufd01pb
2 May 19
Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
7:25am
8-K
8l4z20m9l6jdmuz
19 Mar 19
Other Events
9:08pm
424B5
8rz857rt af
27 Feb 19
Prospectus supplement for primary offering
8:04am
424B5
ygcead138am93
25 Feb 19
Prospectus supplement for primary offering
4:07pm